ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of Onartuzumab (MetMAb) in Combination With Bevacizumab Compared to Bevacizumab Alone or Onartuzumab Monotherapy in Participants With Recurrent Glioblastoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01632228
Recruitment Status : Completed
First Posted : July 2, 2012
Last Update Posted : February 5, 2018
Sponsor:
Information provided by (Responsible Party):
Hoffmann-La Roche

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : January 21, 2016
  Actual Study Completion Date : January 21, 2016
  Certification/Extension First Submitted : January 19, 2017